T1	Participants 107 156	normal subjects and patients with type 1 diabetes
T2	Participants 291 361	seven normal men and nine insulin-dependent (type 1) diabetic patients
T3	Participants 370 380	normal men
T4	Participants 678 695	diabetic patients
T5	Participants 1153 1337	normal men, insulin administration resulted in a significant decline of basal plasma glucagon and C-peptide levels and in a clear-cut decrease in the arginine-induced glucagon response
T6	Participants 1477 1625	insulin-dependent diabetic patients, the lower dose of insulin infused continuously did not alter the basal or arginine-stimulated glucagon response
